These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 5485178

  • 1. Anticoagulation by ancrod for haemodialysis.
    Hall GH, Holman HM, Webster AD.
    Br Med J; 1970 Dec 05; 4(5735):591-3. PubMed ID: 5485178
    [Abstract] [Full Text] [Related]

  • 2. Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.
    Româo JE, Fadil MA, Sabbaga E, Marcondes M.
    Nephrol Dial Transplant; 1997 Jan 05; 12(1):106-10. PubMed ID: 9027783
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic defibrination by ancrod (Arvin).
    Reid HA.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971 Jan 05; 95(2):209-15. PubMed ID: 4106010
    [No Abstract] [Full Text] [Related]

  • 4. A quantitative evaluation of anticoagulants in experimental nephrotoxic nephritis.
    Thomson NM, Simpson IJ, Peters DK.
    Clin Exp Immunol; 1975 Feb 05; 19(2):301-8. PubMed ID: 1212801
    [Abstract] [Full Text] [Related]

  • 5. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
    Skagerlind MSE, Stegmayr BG.
    Eur J Clin Pharmacol; 2018 Mar 05; 74(3):267-274. PubMed ID: 29198062
    [Abstract] [Full Text] [Related]

  • 6. Review: anticoagulation for haemodialysis.
    Suranyi M, Chow JS.
    Nephrology (Carlton); 2010 Jun 05; 15(4):386-92. PubMed ID: 20609088
    [Abstract] [Full Text] [Related]

  • 7. The treatment of deep vein thrombosis of the lower limb: a comparison of arvin (Ancrod) and heparin by a double-blind technique.
    Davies JA, Merrick MV, Sharp AA, Holt JM.
    Br J Haematol; 1972 May 05; 22(5):640. PubMed ID: 4555717
    [No Abstract] [Full Text] [Related]

  • 8. Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass.
    Zulys VJ, Teasdale SJ, Michel ER, Skala RA, Keating SE, Viger JR, Glynn MF.
    Anesthesiology; 1989 Dec 05; 71(6):870-7. PubMed ID: 2589675
    [Abstract] [Full Text] [Related]

  • 9. Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin.
    Kakkar VV, Flanc C, Howe CT, O'Shea M, Flute PT.
    Br Med J; 1969 Mar 29; 1(5647):806-10. PubMed ID: 4886628
    [Abstract] [Full Text] [Related]

  • 10. Arvin anticoagulation for prolonged extracorporeal membrane oxygenation.
    Büky B, Bell W, Matthews P, Reidy T, White JJ.
    Trans Am Soc Artif Intern Organs; 1973 Mar 29; 19():56-60. PubMed ID: 4722775
    [No Abstract] [Full Text] [Related]

  • 11. Ancrod: a practical alternative to heparin.
    Cole CW, Bormanis J.
    J Vasc Surg; 1988 Jul 29; 8(1):59-63. PubMed ID: 3385879
    [Abstract] [Full Text] [Related]

  • 12. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S, Canivet E, Wuillai A, Maheut H, Randoux C, Bonnet JM, Renaux JL, Chanard J.
    Nephrol Dial Transplant; 2003 Oct 29; 18(10):2097-104. PubMed ID: 13679486
    [Abstract] [Full Text] [Related]

  • 13. Platelet electrophoresis: effect of defibrination by ancrod (Arvin).
    Turpie AG, McNicol GP, Douglas AS.
    Cardiovasc Res; 1972 Jan 29; 6(1):101-8. PubMed ID: 5014274
    [No Abstract] [Full Text] [Related]

  • 14. Early postischaemic renal fibrin deposition and reduction of glomerular filtration rate in the rat: effect of the defibrinating agent Arwin.
    Losonczy G.
    Acta Physiol Hung; 1985 Jan 29; 66(2):183-7. PubMed ID: 4050462
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD, Müller U, Lanzmich R, Groeger C, Floege J.
    Nephrol Dial Transplant; 2006 Apr 29; 21(4):1013-8. PubMed ID: 16326745
    [Abstract] [Full Text] [Related]

  • 16. Further experience in the use of ancrod (Arvin) to prevent thrombosis on prosthetic heart valves.
    Singh MP, Pitney WR, Melrose DG.
    Thorax; 1971 Mar 29; 26(2):167-71. PubMed ID: 5576533
    [Abstract] [Full Text] [Related]

  • 17. Effects of ancrod and rtPA on fibrin accumulation, glomerular inflammation and renal function in nephrotoxic nephritis.
    Mathieson PW, Thiru S, Peters DK, Oliveira DB.
    Int J Exp Pathol; 1991 Dec 29; 72(6):679-93. PubMed ID: 1768613
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulation options for intermittent haemodialysis.
    Davenport A.
    Minerva Urol Nefrol; 2006 Jun 29; 58(2):171-80. PubMed ID: 16767070
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV, Schwartz ML, Hill RL, McKee PA.
    J Clin Invest; 1972 Nov 29; 51(11):2841-50. PubMed ID: 4263497
    [Abstract] [Full Text] [Related]

  • 20. A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis.
    Tipping PG, Thomson NM, Holdsworth SR.
    Br J Exp Pathol; 1986 Aug 29; 67(4):481-91. PubMed ID: 3741774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.